Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR: Bioanalytical challenges and strategies of T-cell engager therapeutics 8 days 4 hours 45 mins 54 secs REGISTER NOW

Poster: The use of fragment ion and collision cross section for confident identification from LC-ION mobility-MS metabolomics data (Waters Corporation)

7 Oct 2014
General interest

A novel and confident identification of metabolomics and lipidomics UPLC-ion mobility MS datasets
bases on fragment ion and collision cross section.


Click here to view poster

Related Links

  • Waters Corporation

 

Top content

  • Small molecule method development strategies with Chad Christianson
  • New AI tool predicts multiple sclerosis drug response
  • Waters upgrade Xevo MRT performance: who doesn’t want sharper, faster imaging?

Related tags

LC metabolomics MS
Previous article

Related articles

20 NOV 2014 JOURNAL ARTICLES
Recent developments in urinalysis of metabolites of new psychoactive substances using LC–MS
15 AUG 2012 CHROMATOGRAPHY
The use of selected reaction monitoring in quantitative proteomics
10 OCT 2017 MS (LC–MS/MS, HRMS, IMS)
What are ion mobility MS and collision cross section data?
22 MAY 2014 GENERAL INTEREST
New combination of biomarkers identified for the detection of Alzheimer’s disease
20 JUL 2020 GENERAL INTEREST
The importance of metabolomics: an interview with Chris Zhu
21 OCT 2015 DRUG DEVELOPMENT
Press release: Bruker introduces the Molecular Drug Imager™ solution for small molecule drug discovery and development
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone